THIS
SUBSCRIPTION AGREEMENT IS EXECUTED IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION 4(2) AND REGULATION D, RULE 506 FOR TRANSACTIONS
NOT INVOLVING A PUBLIC OFFERING UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS OFFERING
IS BEING MADE TO ACCREDITED INVESTORS PURSUANT TO REGULATION D PROMULGATED UNDER THE SECURITIES ACT. NONE OF THE SECURITIES TO
WHICH THIS SUBSCRIPTION RELATES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO
REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION D OR UNDER
THE SECURITIES ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN EACH CASE ONLY IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN
ACCORDANCE WITH THE SECURITIES ACT.


 


MILLENNIUM HEALTHCARE
INC.


 


SUBSCRIPTION AGREEMENT


 


SUBSCRIPTION
AGREEMENT (“Subscription Agreement”) made as of this ___ day of __________, 2014 between Millennium Healthcare Inc.,
a Delaware corporation located at 400 Garden City Plaza, Suite 440, Garden City, NY, 11530 (the “Company”), and the
undersigned (the “Subscriber”).


 


WHEREAS,
the Company is conducting a private offering (the “Offering”) of up to $3,000,000 (“Maximum Offering Amount”)
of the Company’s units (“Unit”), each Unit consisting of one (1) share of common stock, par value $0.0001 per
share (“Common Stock” and such shares of Common Stock issued, the “Common Shares”) and one (1) share of
Series F Preferred Stock, par value $0.0001 per share (“Series F Preferred Stock” and such shares of Series F Preferred
Stock issued, the “Preferred Shares”), having the rights, preferences and limitations as set forth in the Certificate
of Designation, in the form of Exhibit A hereto (“Certificate of Designation”), at a purchase price of $1.00
per unit. The Offering is being made exclusively to accredited investors pursuant to an exemption from registration provided under
Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Rule 506 promulgated thereunder;
and


 


WHEREAS,
the Subscriber desires to purchase that number of Units set forth on such signature page hereof on the terms and conditions hereinafter
set forth.


 


NOW,
THEREFORE, in consideration of the premises and the mutual representations and covenants hereinafter set forth, the parties hereto
do hereby agree as follows:


 


I.           SUBSCRIPTION
FOR UNITS; COVENANTS OF THE COMPANY


 


1.1           Subscription for
Units. Subject to the terms and conditions hereinafter set forth, the Subscriber hereby irrevocably subscribes for and agrees to
purchase from the Company, and the Company agrees to sell to the Subscriber, such number of Units as is set forth on the signature
page hereof. The purchase price is payable by wire transfer to the Company in accordance with the wire instructions set forth on
Exhibit C attached hereto.


 






    	1



    	 



    

 


1.2           Offering
Period. The Units will be offered for sale until the earlier of (i) the date upon which subscriptions for the Maximum Offering
offered hereunder have been accepted, (ii) January 31, 2014 (subject to the right of the Company to extend the Offering until June
30, 2014 without further notice to investors), or (iii) the date upon which the Company elects to terminate the Offering (the “Termination
Date”). The Offering is being conducted on a “best-efforts” basis.


 


1.3           Closing.
The Company may hold an initial closing (“Initial Closing”) at any time after the receipt of accepted
subscriptions from qualified investors prior to the Termination Date. After the Initial Closing, subsequent closings with
respect to additional Units may take place at any time prior to the Termination Date as determined by the Company, with
respect to subscriptions accepted prior to the Termination Date (each such closing, together with the Initial Closing, being
referred to as a “Closing”). The last Closing of the Offering, occurring on or prior to the Termination Date,
shall be referred to as the “Final Closing”. Any subscription documents or funds received after the Final Closing
will be returned, without interest or deduction. In the event that the any Closing does not occur prior to the Termination
Date, all amounts paid by the Subscriber shall be returned to the Subscriber, without interest or deduction.


 


II.            REPRESENTATIONS
AND WARRANTIES OF THE SUBSCRIBER


 


The Subscriber represents
and warrants to the Company, with the intent that the Company will rely thereon, that:


 


2.1           Accredited Investor.
The Subscriber is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the
Securities Act, it is able to bear the economic risk of any investment in the Securities and the information furnished in the accompanying
investor questionnaire, which is attached hereto as Exhibit B, is accurate and complete in all material respects.


 


2.2           Reliance
on Exemptions. The Subscriber acknowledges that the Offering has not been reviewed by the Securities and Exchange Commission (the
“Commission”) or any state agency because it is intended to be an offering exempt from the registration requirements
of the Securities Act and state securities laws. The Subscriber understands that the Company is relying in part upon the truth
and accuracy of, and the Subscriber’s compliance with the representations, warranties, agreements, acknowledgments and understandings
of the Subscriber set forth herein in order to determine the availability of such exemptions and the eligibility of the Subscriber
to acquire the Units.


 


2.3           Investment
Purpose. The Subscriber is purchasing the Units as principal for its own account. The Subscriber is purchasing the Units for investment
purposes only and not with an intent or view towards further sale or distribution (as such term is used in Section 2(11) of the
Securities Act) thereof, and has not pre-arranged any sale with any other purchaser and has no plans to enter into any such agreement
or arrangement. 


 


2.4           Risk
of Investment. The Subscriber recognizes that the purchase of the Units involves a extremely high degree of risk in that: (a) an
investment in the Company is highly speculative and only investors who can afford the loss of their entire investment should consider
investing in the Company and the Units; (b) transferability of the Common Shares and the Preferred Shares are limited; and (c)
the Company may require substantial additional funds in the short term to operate its business and subsequent equity financings
will dilute the ownership and voting interests of Subscriber. The company conducts its business in a highly regulated area of healthcare.


 






    	2



    	 



    

 


2.5           No
Registration. The Common Shares and the Preferred Shares have not been registered under the Securities Act or any state securities
laws and may not be transferred, sold, assigned, hypothecated or otherwise disposed of unless registered under the Securities Act
and applicable state securities laws or unless an exemption from such registration is available (including, without limitation,
under Rule 144 of the Securities Act, as such rule may be amended, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect (“Rule 144”)). The Subscriber represents and warrants and hereby agrees that all
offers and sales of the Common Shares and the Preferred Shares shall be made only pursuant to such registration or to such exemption
from registration.


 


2.6           Prior
Investment Experience. The Subscriber is sufficiently experienced in financial and business matters to be capable of evaluating
the merits and risks of its investments, and to make an informed decision relating thereto, and to protect its own interests in
connection with the purchase of the Units.


 


2.7           Information.
The Subscriber acknowledges careful review of this Subscription Agreement, including the Certificate of Designation and all other
exhibits thereto (collectively, the “Offering Documents”) as well as the Company’s filings with the Commission,
as required pursuant to the Securities and Exchange Act of 1934, as amended (the “Exchange Act”) which are available
on the Internet at www.sec.gov, all of which the undersigned acknowledges have been provided to the undersigned. The undersigned
has been given the opportunity to ask questions of, and receive answers from, the Company concerning the terms and conditions of
this Offering and the Offering Documents and to obtain such additional information, to the extent the Company possesses such information
or can acquire it without unreasonable effort or expense, necessary to verify the accuracy of same as the undersigned reasonably
desires in order to evaluate the investment. The undersigned understands the Offering Documents, and the undersigned has had the
opportunity to discuss any questions regarding any of the Offering Documents with its counsel or other advisor. Notwithstanding
the foregoing, the only information upon which the undersigned has relied is that set forth in the Offering Documents. The undersigned
has received no representations or warranties from the Company, its employees, agents or attorneys in making this investment decision
other than as set forth in the Offering Documents. The undersigned does not desire to receive any further information.


 


2.8           Investment Decision.
In making the decision to invest in the Units the Subscriber has relied solely upon the information provided by the Company in
the Offering Materials. To the extent necessary, the Subscriber has retained, at its own expense, and relied upon appropriate professional
advice regarding the investment, tax and legal merits and consequences of this Subscription Agreement and the purchase of the Units
hereunder. The Subscriber disclaims reliance on any statements made or information provided by any person or in the course of Subscriber’s
consideration of an investment in the Units other than the Offering Documents.


 


2.9           No
Representations. The Subscriber hereby represents that, except as expressly set forth in the Offering Documents, no representations
or warranties have been made to the Subscriber by the Company or any agent, employee or affiliate of the Company, and in entering
into this transaction the Subscriber is not relying on any information other than that contained in the Offering Documents and
the results of independent investigation by the Subscriber.


 


2.10           Tax
Consequences. The Subscriber acknowledges that the Offering may involve tax consequences and that the contents of the Offering
Documents do not contain tax advice or information. The Subscriber acknowledges that it must retain its own professional advisors
to evaluate the tax and other consequences of an investment in the Units.


 






    	3



    	 



    

 


2.11           No
Recommendation or Endorsement. The Subscriber understands that no federal, state or other regulatory authority has passed on or
made any recommendation or endorsement of the Units. Furthermore, the foregoing authorities have not confirmed the accuracy or
determined the adequacy of this Subscription Agreement. Any representation to the contrary is a criminal offense.


 


2.12           No
General Solicitation. The Subscriber represents that the Subscriber was not induced to invest by any form of general solicitation
or general advertising including, but not limited to, the following: (a) any advertisement, article, notice or other communication
published in any newspaper, magazine or similar media or broadcast over the news or radio; and (b) any seminar or meeting whose
attendees were invited by any general solicitation or advertising.


 


2.13           The
Subscriber. The Subscriber (i) if a natural person, represents that the Subscriber has reached the age of 21 and has full power
and authority to execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry
out the provisions hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association,
joint stock company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific
purpose of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state
of its organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation
of state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver
this Subscription and all other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase
and hold the Units, the execution and delivery of this Subscription has been duly authorized by all necessary action, this Subscription
Agreement has been duly executed and delivered on behalf of such entity and is a legal, valid and binding obligation of such entity;
or (iii) if executing this Subscription Agreement in a representative or fiduciary capacity, represents that it has full power
and authority to execute and deliver this Subscription in such capacity and on behalf of the subscribing individual, ward, partnership,
trust, estate, corporation, or limited liability company or partnership, or other entity for whom the Subscriber is executing this
Subscription Agreement, and such individual, partnership, ward, trust, estate, corporation, or limited liability company or partnership,
or other entity has full right and power to perform pursuant to this Subscription and make an investment in the Company, and represents
that this Subscription constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription
Agreement will not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the
Subscriber is a party or by which it is bound;


 


2.14           Legends. The
Subscriber consents to the placement of a legend on any certificate or other document evidencing the Common Shares and the Preferred
Shares, that such securities have not been registered under the Securities Act or any state securities or “blue sky”
laws and setting forth or referring to the restrictions on transferability and sale thereof contained in this Subscription Agreement.
The Subscriber is aware that the Company will make a notation in its appropriate records with respect to the restrictions on the
transferability of such Common Shares and Preferred Shares. The legend to be placed on each certificate shall be in form substantially
similar to the following:


 


 



    	4



    	 



    

 





THESE SECURITIES HAVE
BEEN ISSUED PURSUANT TO THE EXEMPTION FROM THE REGISTRATION PROVISIONS UNDER THE SECURITIES ACT OF 1933, AS AMENDED PROVIDED BY
RULE 506 OF REGULATION D UNDER SUCH ACT AND/OR SECTION 4(2) OF SUCH ACT. THESE SECURITIES CANNOT BE TRANSFERRED, OFFERED, OR SOLD
UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT IS AVAILABLE.


  


The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of the Common
Shares and the Preferred Shares upon which it is stamped, if (a) such Preferred Shares are being sold pursuant to a registration
statement under the Securities Act, (b) such holder delivers to the Company an opinion of counsel, in a reasonably acceptable form,
to the Company that a disposition of the Common Shares and the Preferred Shares is being made pursuant to an exemption from such
registration, or (c) such holder provides the Company with reasonable assurance that a disposition of the Preferred Shares may
be made pursuant to the Rule 144 under the Securities Act without any restriction as to the number of securities acquired as of
a particular date that can then be immediately sold.


 


2.15           Address.
The Subscriber hereby represents that the address of the Subscriber furnished by the Subscriber at the end of this Subscription
Agreement is the undersigned’s principal residence if the Subscriber is an individual or its principal business address if
it is a corporation or other entity.


 


2.16           Survival.
The representations and warranties of the Subscriber contained herein will be true at the date of execution of this Subscription
Agreement by the Subscriber and as of the Closing Date in all material respects as though such representations and warranties were
made as of such times and shall survive the Closing Date and the delivery of the Units. The Subscriber agrees that it will notify
and supply corrective information to the Company immediately upon the occurrence of any change therein occurring prior to the Company’s
issuance of the Units.


 


		III.	REPRESENTATIONS BY THE COMPANY



 


The
Company represents and warrants to the Subscriber, except as set forth in the disclosure schedules attached hereto:


 


3.1           Organization.
The Company is duly organized and validly existing in good standing under the laws of the jurisdiction of its organization. The
Company has full power and authority to own, operate and occupy its properties and to conduct its business as presently conducted,
and is registered or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted
by it or the location of the properties owned or leased by it requires such qualification and where the failure to be so qualified
would have a material adverse effect upon the Company’s financial condition (a “Material Adverse Effect”), and
no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or curtail,
such power and authority or qualification.


 


3.2           Due Authorization
and Valid Issuance. The Company has all requisite power and authority to execute, deliver and perform its obligations under the
Offering Documents, and when executed and delivered by the Company will constitute legal, valid and binding agreements of the Company
enforceable against the Company in accordance with their terms, except as rights to indemnity and contribution may be limited by
state or federal securities laws or the public policy underlying such laws, and except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights
generally, and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability
is considered in a proceeding in equity or at law).


 


 



    	5



    	 



    

 





3.3           Noncontravention.
The execution and delivery of the Offering Documents, the issuance and sale of the Units under the Offering Documents, the fulfillment
of the terms of the Offering Documents, and the consummation of the transactions contemplated thereby will not (i) conflict
with or constitute a violation of, or default (with the passage of time or otherwise) under (1) any material bond, debenture, note
or other evidence of indebtedness, lease, contract, indenture, mortgage, deed of trust, loan agreement, joint venture or other
agreement or instrument to which the Company is a party or by which it or any of its properties are bound, (2) the charter, bylaws
or other organizational documents of the Company or any subsidiary or (3) any law, administrative regulation, ordinance or order
of any court or governmental agency, arbitration panel or authority applicable to the Company or its properties, except for any
such conflicts, violations or defaults that are not reasonably likely to have a Material Adverse Effect, or (ii) result in the
creation or imposition of any lien, encumbrance, claim, security interest or restriction whatsoever upon any of the material properties
or assets of the Company or an acceleration of indebtedness pursuant to any obligation, agreement or condition contained in any
material bond, debenture, note or any other evidence of indebtedness, indenture, mortgage, deed of trust or any other agreement
or instrument to which the Company is a party or by which it is bound or to which any of the material property or assets of the
Company is subject. No consent, approval, authorization or other order of, or registration, qualification or filing with, any regulatory
body, administrative agency, or other governmental body in the United States or any other person is required for the execution
and delivery of the Offering Documents and the valid issuance and sale of the Units to be sold pursuant to the Offering Documents,
other than such as have been made or obtained, and except for any post-closing securities filings or notifications required to
be made under federal or state securities laws.


 


3.4           No Violation.
The Company is not (a) in violation of its charter, bylaws or other organizational document; (b) in violation of any law,


  


IV.          PIGGY-BACK
REGISTRATION RIGHTS


 


If
at any time, the Company shall decide to prepare and file with the Commission a registration statement relating to an offering
for its own account or the account of others under the Securities Act of 1933, as amended (the “Securities Act”) of
any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents
relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities
issuable in connection with the stock option or other employee benefit plans, then the Company shall send to the Subscriber a written
notice of such determination and, if within fifteen days after the date of such notice, the Subscriber shall so request in writing,
the Company shall include in such registration statement, the Common Shares (collectively, the “Registrable Securities”)
the Subscriber requests to be registered; provided, however, that, the Company shall not be required to register
any Registrable Securities pursuant to this Section that are eligible for resale without restriction pursuant to Rule 144 promulgated
under the Securities Act or that are the subject of a then effective registration statement; provided, further, however,:
(a) if the registration statement is an offering to be made on a continuous basis pursuant to Rule 415 and is not on a Form S-3,
and the Commission advises the Company that all of the Registrable Securities which the Subscriber has requested to be registered
may not be included under Rule 415(a)(i), then the number of Registrable Securities to be registered shall be reduced to an amount
to which is permitted by the Commission for resale under Rule 415; and (b) if the registration so proposed by the Company involves
an underwritten offering of the securities so being registered for the account of the Company, to be distributed by or through
one or more underwriters of recognized standing, and the managing underwriter of such underwritten offering shall advise the Company
in writing that, in its opinion, the distribution of all or any specified portion of the Registrable Securities which the Subscriber
has requested the Company to register and otherwise concurrently with the securities being distributed by such underwriters will
materially and adversely affect the distribution of such securities by such underwriters, then the Company shall not be required
to register any shares under the Subscription Agreement.


 






    	6



    	 



    

 


V.           USE
OF PROCEEDS


 


The
proceeds of the Offering will be employed by the Company substantially for general working capital.


 


VI.          INDEMNIFICATION


 


6.1           The
Subscriber agrees to indemnify and hold harmless the Company, placement agent, if any, against and in respect of any and all loss,
liability, claim, damage, deficiency, and all actions, suits, proceedings, demands, assessments, judgments, costs and expenses
whatsoever (including, but not limited to, attorneys' fees reasonably incurred in investigating, preparing, or defending against
any litigation commenced or threatened or any claim whatsoever through all appeals) arising out of or based upon any false representation
or warranty or breach or failure by the Subscriber to comply with any covenant, representation or other provision made by it herein
or in any other document furnished by it in connection with this Subscription Agreement, provided, however, that such indemnity,
shall in no event exceed the net proceeds received by the Company from the Subscriber as a result of the sale of Units to the Subscriber.


 


6.2           The
Company agrees to indemnify and hold harmless the Subscriber against and in respect of any and all loss, liability, claim, damage,
deficiency, and all actions, suits, proceedings, demands, assessments, judgments, costs and expenses whatsoever (including, but
not limited to, attorneys' fees reasonably incurred in investigating, preparing, or defending against any litigation commenced
or threatened or any claim whatsoever through all appeals) arising out of or based upon any false representation or warranty or
breach or failure by the Company to comply with any covenant, representation or other provision made by it herein or in any other
document furnished by it in connection with this Subscription Agreement.


 


VII.          MISCELLANEOUS


 


7.1           Notice.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Subscription Agreement
must be in writing and will be deemed to have been delivered: (a) upon receipt, when delivered personally, (b) upon receipt, when
sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending
party), or (c) one (1) business day after deposit with an overnight courier service, in each case properly addressed to the party
to receive the same. The addresses and facsimile numbers for such communications shall be:


 






    	7



    	 



    




 





To
the Company:






 


Millennium
Healthcare Inc.





400
Garden City Plaza, Suite 440





Garden
City, New York 11530 





Attention:
Dominick Sartorio





Telephone:
516-628-5500


 





 


With
a copy to (which shall not constitute notice):


 


Sichenzia
Ross Friedman Ference LLP





61
Broadway, 32nd Floor 





New
York, New York 10006





Attention:
Andrea Cataneo





Telephone:
212-930-9700





Facsimile:
212-930-9725


 


If
to the Subscriber, to its address and facsimile number set forth at the end of this Subscription Agreement, or to such other address
and/or facsimile number and/or to the attention of such other person as specified by written notice given to the Company five (5)
days prior to the effectiveness of such change. Written confirmation of receipt (a) given by the recipient of such notice, consent,
waiver or other communication, (b) mechanically or electronically generated by the sender’s facsimile machine containing
the time, date, recipient facsimile number and an image of the first page of such transmission, or (c) provided by an overnight
courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from an overnight courier service
in accordance with clause (a), (b) or (c) above, respectively.


 


7.2           Entire
Agreement; Amendment; Waiver. This Subscription Agreement supersedes all other prior oral or written agreements between the Subscriber,
the Company, their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Subscription
Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered
herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Subscriber makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of this Subscription Agreement may be amended or waived
other than by an instrument in writing signed by the Company and the holders of at least a majority of the Units then outstanding
(or if prior to the closing, the Subscribers purchasing at least a majority of the Units to be purchased at the closing). No such
amendment shall be effective to the extent that it applies to less than all of the holders of the Units then outstanding.


 


7.3           Severability.
If any provision of this Subscription Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Subscription Agreement in that jurisdiction or the validity
or enforceability of any provision of this Subscription Agreement in any other jurisdiction.


 






    	8



    	 



    

 


7.4           Governing
Law; Jurisdiction; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of
this Subscription Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the
application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the non-exclusive
jurisdiction of the state and federal courts sitting in New York County, New York for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Subscription Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party hereby irrevocably waives
any right it may have, and agrees not to request, a jury trial for the adjudication of any dispute hereunder or in connection with
or arising out of this Subscription Agreement or any transaction contemplated hereby.


 


7.5           Headings.
The headings of this Subscription Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Subscription Agreement.


 


7.6           Successors
and Assigns. This Subscription Agreement shall be binding upon and inure to the benefit of the parties and their respective successors
and assigns. The Company shall not assign this Subscription Agreement or any rights or obligations hereunder without the prior
written consent of the holders of at least a majority the Units then outstanding, except by merger or consolidation. The Subscriber
shall not assign its rights hereunder without the consent of the Company, which consent shall not be unreasonably withheld.


 


7.7           No
Third Party Beneficiaries. This Subscription Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.


 


7.8           Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order
to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.


 


7.9           Legal
Effect. The Subscriber acknowledges that: (a) it has read this Agreement and the exhibits hereto; and (b) it understands the terms
and consequences of this Agreement and is fully aware of its legal and binding effect.


 


7.10           No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party.


 






    	9



    	 



    

 


7.11           Independent
Legal Advice. The parties hereto acknowledge that they have each received independent legal advice with respect to the terms of
this Agreement and the transactions contemplated herein or have knowingly and willingly elected not to do so


 


7.12           Counterparts.
This Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of which shall together
constitute one and the same instrument. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature
page were an original thereof.


 


 


 


[Signature
page follows.]


 




    	10



    	 



    

 


NUMBER
OF UNITS ______ X $1.00 = $_________ (the “Purchase Price”)           


 


	 	___________________________	____________________________
	 	 Signature	Signature (if purchasing jointly)
	 	 	 
	 	___________________________	____________________________
	 	Name Typed or Printed	Name Typed or Printed
	 	 	 
	 	___________________________	____________________________
	 	Title (if Subscriber is an Entity)	Title (if Subscriber is an Entity)
	 	 	 
	 	___________________________	____________________________
	 	Entity Name (if applicable)	Entity Name (if applicable
	 	 	 
	 	___________________________	____________________________
	 	Address	Address
	 	 	 
	 	___________________________	____________________________
	 	City, State and Zip Code	City, State and Zip Code
	 	 	 
	 	___________________________	____________________________
	 	Telephone-Business	Telephone-Business
	 	 	 
	 	___________________________	____________________________
	 	Telephone-Residence	Telephone-Residence
	 	 	 
	 	___________________________	____________________________
	 	Facsimile-Business	Facsimile-Business
	 	 	 
	 	___________________________	____________________________
	 	Facsimile-Residence	Facsimile-Residence
	 	 	 
	 	 	 
	 	Tax ID # or Social Security #	Tax ID # or Social Security # 


 


Name
in which Common Shares and Preferred Shares should be issued:           


 


                                                                                                                


 


Dated:                               
, 2014


 


This
Subscription Agreement is agreed to and accepted as of ________________, 2014.


 


Millennium
Healthcare Inc.


 


	 	By:	____________________________________
	 	Name:	Dominick Sartorio
	 	Title:	Chief Executive Officer 


 


 



    	11



    	 



    




 


CERTIFICATE
OF SIGNATORY


 


(To
be completed if Units are


being
subscribed for by an entity)


 


 


I,
____________________________, am the ____________________________ of 


__________________________________________
(the “Entity”).


 


I
certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Subscription Agreement
and to purchase and hold the Units, and certify further that the Subscription Agreement has been duly and validly executed on behalf
of the Entity and constitutes a legal and binding obligation of the Entity.


 


IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________, 2014


 


 


	 	_______________________________________
	 	(Signature)


 


 


 


 




    	12



    	 



    

EXHIBIT A


CERTIFICATE OF DESIGNATION


 


 


 




    	13



    	 



    

 


EXHIBIT B


ACCREDITED INVESTOR
QUESTIONNAIRE


 


The
undersigned Subscriber is an “accredited investor” as that term is defined in Regulation D promulgated under the Securities
Act and amended by the Dodd-Frank Wall Street Reform and Consumer Protection Act by virtue of being (initial all applicable responses):


 


	______A small business investment company licensed by the U.S. Small Business Administration under the Small Business Investment Company Act of 1958,
	______A business development company as defined in the Investment Company Act of 1940,
	______A national or state-chartered commercial bank, whether acting in an  individual or fiduciary capacity,
	____An insurance company as defined in Section 2(13) of the Securities Act,
	____An investment company registered under the Investment Company Act of 1940,
	_____An employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, where the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, insurance company, or registered investment advisor, or an employee benefit plan which has total assets in excess of $5,000,000,
	_____A private business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940,
	_____An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation or a partnership with total assets in excess of $5,000,000,
	_____A natural person whose individual net worth, or joint net worth with that person's spouse, at the time of purchase exceeds $1,000,000.  For purposes of this Exhibit A-1, “net worth” means the excess of total assets at fair market value over total liabilities. For purposes of calculating net worth under this section, (i) the primary residence shall not be included as an asset, (ii) to the extent that the indebtedness that is secured by the primary residence is in excess of the fair market value of the primary residence, the excess amount shall be included as a liability, and (iii) if the amount of outstanding indebtedness that is secured by the primary residence exceeds the amount outstanding 60 days prior to the execution of this questionnaire, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability.
	_____Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Section 506(b)(2)(ii) of Regulation D,
	_____A natural person who had an individual income in excess of $200,000 in each of the two most recent calendar years, and has a reasonable expectation of reaching the same income level in the current calendar year.  For purposes of this Exhibit A-1, “income” means annual adjusted gross income, as reported for federal income tax purposes, plus (i) the amount of any tax-exempt interest income received; (ii) the amount of losses claimed as a limited partner in a limited partnership; (iii) any deduction claimed for depletion; (iv) amounts contributed to an IRA or Keogh retirement plan; (v) alimony paid; and (vi) any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202 of the Internal Revenue Code of 1986, as amended.
	_____A corporation, partnership, trust or other legal entity (as opposed to a natural person) and all of such entity's equity owners fall into one or more of the categories enumerated above. (Note: additional documentation may be requested).


 


 



    	14



    	 



    




 





	____________________________________	_________________________________
	Name of Subscriber (Print)	Name of Joint Subscriber (if any) (Print) 
	 	 
	____________________________________	_________________________________ 
	Signature of Subscriber	Signature of Joint Subscriber (if any) 
	 	 
	____________________________________	_________________________________ 
	Capacity of Signatory (for entities)	Date 


 


 


 


 


 


 




    	15



    	 



    

 


EXHIBIT C


WIRE INSTRUCTIONS


 


 


 


 


 


 








    	16